Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Fidia Spa ( (IT:FDA) ).
Fidia S.p.A. held its Ordinary Shareholders’ Meeting, approving the 2024 financial statements which reported a significant loss of Euro 9,421 thousand, a substantial increase from the previous year. The company also decided to reduce its share capital to cover accumulated losses. Despite the challenging financial year, Fidia remains optimistic about its future, with a promising order portfolio and a strategic plan aimed at returning to positive EBITDA by 2025, supported by favorable industry forecasts.
More about Fidia Spa
Fidia S.p.A. is an international leader in the field of numerical controls and specializes in the design, production, and marketing of high-performance integrated milling systems. The company is publicly traded on Euronext Milan and focuses on providing advanced technological solutions in the industrial machinery sector.
YTD Price Performance: -78.26%
Average Trading Volume: 3,970,081
Technical Sentiment Signal: Strong Sell
Current Market Cap: €3.14M
For an in-depth examination of FDA stock, go to TipRanks’ Stock Analysis page.